HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1
1 other identifier
interventional
541
1 country
12
Brief Summary
The purpose of this study is to look at a program for women in drug abuse treatment designed to reduce Human Immunodeficiency Virus/Sexually Transmitted Disease (HIV/STD) risk behaviors and reduce unprotected sexual risk behavior.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started May 2004
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2004
CompletedFirst Submitted
Initial submission to the registry
June 8, 2004
CompletedFirst Posted
Study publicly available on registry
June 9, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2005
CompletedJanuary 12, 2017
October 1, 2016
1.4 years
June 8, 2004
January 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
AIDS risk behavior
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (12)
Baart Cdp
Los Angeles, California, 90057, United States
Hartford Dispensary
New Britain, Connecticut, 06051, United States
Staten Island University Hospital
Staten Island, New York, 10309, United States
Addiction Drug Services
Greensboro, North Carolina, 27401, United States
South Light - Life Plus
Raleigh, North Carolina, 27604, United States
South Light - Wakeview
Raleigh, North Carolina, 27604, United States
Comprehensive Addiction Services System
Toledo, Ohio, 43620, United States
The Consortium
Philadelphia, Pennsylvania, 19104, United States
Thomas Jefferson Intensive Sub. Abuse TP
Philadelphia, Pennsylvania, 19107, United States
LRADAC-Lexington-Richmond Alcohol & Drug Council
Columbia, South Carolina, 29204, United States
Evergreen Treatment Services
Seattle, Washington, 98134 1618, United States
Prestera Center for Mental Health Svcs.
Huntington, West Virginia, 25704, United States
Related Publications (2)
Campbell AN, Tross S, Hu MC, Pavlicova M, Kenney J, Nunes EV. Female condom skill and attitude: results from a NIDA Clinical Trials Network gender-specific HIV risk reduction study. AIDS Educ Prev. 2011 Aug;23(4):329-40. doi: 10.1521/aeap.2011.23.4.329.
PMID: 21861607DERIVEDTross S, Campbell AN, Cohen LR, Calsyn D, Pavlicova M, Miele GM, Hu MC, Haynes L, Nugent N, Gan W, Hatch-Maillette M, Mandler R, McLaughlin P, El-Bassel N, Crits-Christoph P, Nunes EV. Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial. J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):581-9. doi: 10.1097/QAI.0b013e31817efb6e.
PMID: 18645513DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Tross, Ph.D.
New York State Psychiatric Institute
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Purpose
- TREATMENT
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 8, 2004
First Posted
June 9, 2004
Study Start
May 1, 2004
Primary Completion
October 1, 2005
Study Completion
October 1, 2005
Last Updated
January 12, 2017
Record last verified: 2016-10